| Name | 5-chloro-3-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-2-oxoethyl]-1,3-benzothiazol-2-one |
|---|---|
| Synonyms |
Tiaramida [INN-Spanish]
USV 2592 5-chloro-3-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-2-oxoethyl]-3H-benzothiazol-2-one TIARAMIDE 5-chloro-3-[4-(2-hydroxyethyl)-1-piperazinyl]carbonylmethyl-2-benzothiazolinone tialamide 1-[(5-chloro-2-oxo-benzothiazol-3-yl)-acetyl]-4-(2-hydroxy-ethyl)-piperazine Tiaramide [INN:BAN] RHC 2592A Tiaramidum [INN-Latin] EINECS 251-083-7 3-[4-(2-hydroxyethyl)-1-piperazinyl]carbonylmethyl-5-chloro-2-benzothiazolinone |
| Density | 1.432g/cm3 |
|---|---|
| Boiling Point | 605.8ºC at 760mmHg |
| Molecular Formula | C15H18ClN3O3S |
| Molecular Weight | 355.84000 |
| Flash Point | 320.2ºC |
| Exact Mass | 355.07600 |
| PSA | 94.02000 |
| LogP | 0.72870 |
| Index of Refraction | 1.64 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
|
~%
32527-55-2 |
| Literature: Fujisawa Pharmaceutical Co., Ltd. Patent: US4242507 A1, 1980 ; |
| Precursor 3 | |
|---|---|
| DownStream 0 | |